VYNE Therapeutics
VYNE
#10151
Rank
NZ$33.55 M
Marketcap
NZ$1.01
Share price
3.04%
Change (1 day)
-83.05%
Change (1 year)

Market capitalization of VYNE Therapeutics (VYNE)

Market cap: NZ$33.55 Million

As of January 2026 VYNE Therapeutics has a market cap of NZ$33.55 Million. This makes VYNE Therapeutics the world's 10151th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of VYNE Therapeutics from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$33.79 M-59.24%
2024NZ$82.91 M61.24%
2023NZ$51.42 M275.05%
2022NZ$13.71 M-82.84%
2021NZ$79.91 M-78.88%
2020NZ$0.37 B125.09%
2019NZ$0.16 B17.81%
2018NZ$0.14 B
2026NZ$33.55 M-0.72%

End of Day market cap according to different sources

On Jan 1st, 2026 the market cap of VYNE Therapeutics was reported to be:

NZ$33.3 Million
by Nasdaq info icon info icon
NZ$33.55 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.38 B 4,025.67%๐Ÿ‡บ๐Ÿ‡ธ USA